{"document": {"publication": "Tag My News", "full_text": "celgene corp's cancer drug, revlimid, significantly extended the lives of patients with multiple myeloma who took the drug as a maintenance therapy following a stem cell transplant.", "title": "celgene's revlimid extends life in cancer trial", "line_count": 1, "filename": "1998", "publication_date": "05-05-2011 19:50:23", "lines_and_colors": [["celgene corp's cancer drug, revlimid, significantly extended the lives of patients with multiple myeloma who took the drug as a maintenance therapy following a stem cell transplant.", {}]]}}